- Home
- FLWS vs EDIT Comparison
FLWS vs EDIT Comparison
Compare FLWS & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLWS | EDIT |
|---|---|---|
| Founded | 1976 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 196.7M | 233.3M |
| IPO Year | 1999 | 2016 |
Fundamental Metrics
Financial Performance| Metric | FLWS | EDIT |
|---|---|---|
| Price | $4.36 | $2.47 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 10 |
| Target Price | ★ $7.50 | $4.13 |
| AVG Volume (30 Days) | 1.1M | ★ 1.6M |
| Earning Date | 01-29-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,658,768,000.00 | $46,383,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.93 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.93 | $0.91 |
| 52 Week High | $9.17 | $4.54 |
Technical Indicators
Market Signals| Indicator | FLWS | EDIT |
|---|---|---|
| Relative Strength Index (RSI) | 58.48 | 44.80 |
| Support Level | $3.88 | $2.09 |
| Resistance Level | $5.18 | $2.70 |
| Average True Range (ATR) | 0.39 | 0.17 |
| MACD | 0.13 | 0.05 |
| Stochastic Oscillator | 61.02 | 61.48 |
Price Performance
Historical ComparisonAbout FLWS 1-800-FLOWERS.COM Inc.
1-800-Flowers.com Inc is a provider of gifts designed to help customers express, connect, and celebrate. The company's e-commerce business platform features all brands, including 1-800-Flowers.com, 1-800-Baskets.com, Cheryl's Cookies, Harry and David, PersonalizationMall.com, Shari's Berries, FruitBouquets.com, Moose Munch, The Popcorn Factory, Wolferman's Bakery, Stock Yards, and Simply Chocolate. The company's business segments are; Consumer Floral and Gifts, BloomNet, and Gourmet Foods & Gift Baskets. The maximum revenue for the company is generated from its Gourmet Foods & Gift Baskets segment.
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.